Impedimed Limited is a medical technology company based in Pinkenba, Australia, specializing in the development of non-invasive diagnostic tools for the assessment and management of lymphedema and other fluid-related conditions. The company focuses on bioimpedance spectroscopy technology, which provides clinicians with critical information to improve patient outcomes. Impedimed's innovative solutions are designed to enhance the quality of care in oncology and other healthcare settings, emphasizing patient-centric approaches and advanced medical insights.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

29 Patents

#1 in Pinkenba

#113 in Australia

#22,552 in the World

Pinkenba, Australia

Impedimed Limited

Forward Citations = 141

33 inventors:

Scott Chetham (10 out of 14 patents)

Leigh Cordwin Ward (9 out of 10 patents)

Tim Essex (3 out of 5 patents)

4. Bruce Herbert Cornish (3 out of 4 patents)

5. Richelle Leanne Gaw (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Impedimed Limited. Retrieved from https://idiyas.com/company/impedimed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

26 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]